Improvement effect of 5-aminolevulinic acid on hyperlipidemia in miniature schnauzer dogs: An open study in 5 cases of one pedigree

4Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

Abstract

This is the first study to examine the long-term effect of 5-aminolevulinic acid mainly on serum lipoproteins in dogs with hyperlipidemia. We studied 5 Miniature Schnauzer cases whose fasting serum total triglyceride and very-low-density lipoprotein of triglyceride levels were extremely high (635 ± 116 and 520 ± 92 mg/dL, respectively). Although the total cholesterol values were normal, the very-low-density lipoprotein of cholesterol level was high (49 ± 7 mg/dL). Each dog received a 5-aminolevulinic acid supplement (5 mg/day) orally for 6 months. The mean values of total triglyceride, very-low-density lipoprotein of both triglyceride and cholesterol decreased significantly after the treatment period (319 ± 29, 245 ± 18, and 27 ± 2 mg/dL, respectively, P <0.05). Our present results may present evidence that 5-ALA administration contributes to improvement of hyperlipidemia in Miniature Schnauzer.

Cite

CITATION STYLE

APA

Sakai, A., Iwatani, N., & Harada, K. (2020). Improvement effect of 5-aminolevulinic acid on hyperlipidemia in miniature schnauzer dogs: An open study in 5 cases of one pedigree. Yonago Acta Medica, 63(3), 234–238. https://doi.org/10.33160/yam.2020.08.006

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free